Unknown PHASE4 INTERVENTIONAL 2-arm NCT00912756

Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC)

Evaluation of Antiplatelet Therapy in Lower Limb Endovascular Treatment

Sponsor: Association for Establishment of Ebvidence in Interventions

Interventions cilostazol

Updated 6 times since 2017 Last updated: Jul 21, 2010 Started: Mar 31, 2009 Primary completion: Jun 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Arteriosclerosis Obliterans and is currently ongoing. Association for Establishment of Ebvidence in Interventions leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Association for Establishment of Ebvidence in Interventions
Kansai Rosai Hospital

Data source: Kansai Rosai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amagasaki, Japan , Kanazawa, Japan , Kishiwada, Japan , Kitakyusy, Japan , Kurume, Japan , Matsumoto, Japan , Nagano, Japan , Nishinomiya, Japan , Sapporo, Japan , Sendai, Japan and 2 more locations